Fatal Heart Attack Leads to Testosterone Treatment Wrongful Death Lawsuit

TRT Wrongful Death Suit

Start Claim Now

Fatal Heart Attack Leads to Testosterone Treatment Wrongful Death Lawsuit

A man’s heart attack death was caused by his use of AndroGel and Axiron testosterone medications for only six months, according to a wrongful death complaint filed by his son.

The son of a Delaware man has brought a wrongful death lawsuit against the makers of the testosterone treatments Axiron and AndroGel, alleging that side effects of the medications caused his father to suffer a fatal heart attack. The lawsuit was filed last month by Richard Sean Ott in the U.S. District Court for the Northern District of Illinois, and seeks damages from Eli Lilly and Company, AbbVie Inc., and Abbott Laboratories. If you have experienced a heart attack or stroke, and you believe a low T treatment like AndroGel or Axiron to be the cause, our consumer advocates at the Consumer Justice Foundation can help. We are dedicated to protecting the rights of consumers harmed by dangerous drugs, and can put you in touch with a knowledgeable testosterone therapy lawyer today.

Low T Treatment Linked to Heart Attack

According to allegations raised in the testosterone therapy lawsuit, Richard Bodwell Ott died in April 2012, after suffering a fatal heart attack. Richard Sean Ott indicates in the complaint that his father was 58 years old when he was first prescribed the testosterone drug AndroGel in October 2011, and had no history of heart disease prior to his heart attack. Ott reportedly used AndroGel until January 2012, at which point he was prescribed Axiron testosterone gel, which he took from April 2012 until his heart attack and death. In the lawsuit, Richard Sean Ott alleges that his father was encouraged to use testosterone therapy after seeing advertisements for low T treatments.

Lawsuits Over TRT Complications

According to the wrongful death complaint, the makers of the testosterone treatments made false and misleading statements about the safety and efficacy of AndroGel and Axiron in raising testosterone levels, when they actually increased Ott’s risk of experiencing a deadly heart attack. Ott’s wrongful death lawsuit joins a growing number of complaints involving side effects of testosterone replacement therapy (TRT), which research shows can increase a man’s risk of suffering serious and potentially life-threatening cardiovascular events, including heart attack, blood clots, stroke and death.

Cardiovascular Risks Tied to Testosterone Therapy

A growing number of lawsuits are being filed against the makers of testosterone drugs like AndroGel and Axiron, as more and more consumers become aware of a series of studies that link TRT to severe cardiovascular risks. In November 2013, a study published in the Journal of the American Medical Association indicated that low T treatments may increase the risk of cardiovascular events among older men with certain preexisting heart conditions. In another study published in January 2014, researchers found that side effects of testosterone drugs may double the risk of heart attack for younger men with heart disease, and men over 65 regardless of their heart health.

Contact a Testosterone Treatment Lawyer Today

If you took a testosterone drug like Axiron or AndroGel, and you have since suffered a devastating cardiovascular event like heart attack or stroke, contact an experienced testosterone therapy attorney today to discuss your legal options. You may have grounds to file a product liability lawsuit against the manufacturing company, in order to pursue financial compensation for your injuries and medical expenses.

Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.
×